The Bombay High Court has granted
relief to Swiss pharmaceutical major Galderma Holdings in an intellectual
property (IP) enforcement action against counterfeit products bearing its
‘CETAPHIL’ trademark. Galderma, acting through its Indian subsidiary Galderma
India, had approached the Court seeking urgent measures to address large-scale
counterfeiting of its products across online platforms and local markets.
On 18 June, the Court issued a John
Doe injunction order, permitting the company to take immediate action against
unidentified infringers. Following the order, search and seizure operations
were carried out by a team from Khaitan and Co. on 2 July in collaboration with
the police and Court Receivers. The enforcement team conducted searches at
manufacturing and trading locations in New Delhi and Mumbai.